Oppenheimer Asset Management’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $237K | Sell |
|
|||||
|
2025
Q1 | $259K | Buy |
|
|||||
|
2024
Q4 | $251K | Sell |
|
|||||
|
2024
Q3 | $361K | Buy |
|
|||||
|
2024
Q2 | $264K | Buy |
|
|||||
|
2024
Q1 | $295K | Buy |
|
|||||
|
2023
Q4 | $301K | Sell |
|
|||||
|
2023
Q3 | $254K | Buy |
|
|||||
|
2023
Q2 | $327K | Buy |
|
|||||
|
2023
Q1 | $210K | Buy |
|
|||||
|
2022
Q4 | $238K | Buy |
|
|||||
|
2022
Q3 | – | Sell |
|
|||||
|
2022
Q2 | $206K | Sell |
|
|||||
|
2022
Q1 | $302K | Buy |
|
|||||
|
2021
Q4 | $304K | Sell |
|
|||||
|
2021
Q3 | $334K | Buy |
|
|||||
|
2021
Q2 | – | Sell |
|
|||||
|
2021
Q1 | $209K | Sell |
|
|||||
|
2020
Q4 | $346K | Sell |
|
|||||
|
2020
Q3 | $265K | Buy |
|
|||||
|
2020
Q2 | – | Sell |
|
|||||
|
2020
Q1 | $100K | Buy |
|
|||||
|
2019
Q4 | $33K | Buy |
|
|||||
|
2019
Q3 | $31K | Buy |
|
|||||
|
2019
Q2 | $45K | Sell |
|
|||||
|
2019
Q1 | $74K | Sell |
|
|||||
|
2018
Q4 | $55K | Buy |
|
|||||
|
2017
Q4 | – | Sell |
|
|||||
|
2017
Q3 | $20K | Buy |
|
|||||
|
2017
Q2 | $21K | Buy |
|
|||||
|
2017
Q1 | $16K | Buy |
|